Adipose Inflammation and Diabetes (FAB)

NCT04255264 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2025-05-06

No results posted yet for this study

Summary

The study investigates whether the addition of resolution molecules can inhibit inflammation and insulin resistance in human tissue taken from obese individuals, and whether the results of these studies correlate with patient-specific resolution phenotypes.

Conditions

Sponsors & Collaborators

  • Göteborg University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2026-06-30
Completion
2027-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04255264 on ClinicalTrials.gov